Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 4207441)

Published in Clinicoecon Outcomes Res on October 17, 2014

Authors

Yuanlin Song1, Yicheng Yang2, Wendong Chen3, Wei Liu2, Kai Wang2, Xuehai Li4, Ke Wang2, Manny Papadimitropoulos5, William Montgomery6

Author Affiliations

1: Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
2: Lilly Suzhou Pharmaceutical Co, Ltd, Shanghai Branch, Shanghai, People's Republic of China.
3: Division of Social and Administrative Pharmacy, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada ; Normin Health, Toronto, ON, Canada.
4: VitalStrategic Research Institute, Shanghai, People's Republic of China.
5: Division of Social and Administrative Pharmacy, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada ; Global Health Outcomes Research, Eli Lilly, Indianapolis, IN, USA.
6: Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia.

Articles cited by this

Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med (2005) 23.85

International study of the prevalence and outcomes of infection in intensive care units. JAMA (2009) 11.57

Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis (2012) 7.97

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest (2003) 5.64

Estimating treatment effects using observational data. JAMA (2007) 4.12

Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study. Clin Infect Dis (2009) 2.54

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin Infect Dis (2001) 2.19

International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control (2011) 2.13

Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol (2012) 1.82

Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol (2008) 1.68

Hospital utilization, costs, and mortality for adults with multiple chronic conditions, Nationwide Inpatient Sample, 2009. Prev Chronic Dis (2013) 1.26

Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries. Am J Infect Control (2008) 1.21

Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients. Ann Intensive Care (2011) 0.96

[Adult hospital acquired pneumonia: a multicenter study on microbiology and clinical characteristics of patients from 9 Chinese cities]. Zhonghua Jie He He Hu Xi Za Zhi (2012) 0.95

Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs. J Hosp Infect (2013) 0.91

Modeling the health care costs of geriatric inpatients. IEEE Trans Inf Technol Biomed (2006) 0.81

[A two-year prospective survey on nosocomial infections]. Zhonghua Yi Xue Za Zhi (1991) 0.81

Clinical relevance of linezolid-associated serotonin toxicity. Ann Pharmacother (2013) 0.79

[Analysis of nosocomial infection in hospitalized critical and serious patients]. Zhonghua Liu Xing Bing Xue Za Zhi (1995) 0.78

[Nosocomial pneumonia: a report of 372 cases]. Zhonghua Nei Ke Za Zhi (1992) 0.77